Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036358487> ?p ?o ?g. }
- W3036358487 endingPage "7915" @default.
- W3036358487 startingPage "7908" @default.
- W3036358487 abstract "Nanostructures play an important role in targeting sparingly water-soluble drugs to specific sites. Because of the structural flexibility and stability, the use of template microemulsions (μEs) can produce functional nanopharmaceuticals of different sizes, shapes, and chemical properties. In this article, we report a new volatile oil-in-water (o/w) μE formulation comprising ethyl acetate/ethanol/brij-35/water to obtain the highly water-dispersible nanoparticles of an antihyperlipidemic agent, ezetimibe (EZM-NPs), to enhance its dissolution profile. A pseudoternary phase diagram was delineated in a specified brij-35/ethanol ratio (1:1) to describe the transparent, optically isotropic domain of the as-formulated μE. The water-dilutable μE formulation, comprising an optimum composition of ethyl acetate (18.0%), ethanol (25.0%), brij-35 (25.0%), and water (32.0%), showed a good dissolvability of EZM around 4.8 wt % at pH 5.2. Electron micrographs showed a fine monomodal collection of EZM-loaded μE droplets (∼45 nm) that did not coalesce even after lyophilization, forming small spherical EZM-NPs (∼60 nm). However, the maturity of nanodrug droplets observed through dynamic light scattering suggests the affinity of EZM to the nonpolar microenvironment, which was further supported through peak-to-peak correlation of infrared analysis and fluorescence measurements. Moreover, the release profile of the as-obtained EZM-nanopowder increased significantly >98% in 30 min, which indicates that a reduced drug concentration will be needed for capsules or tablets in the future and can be simply incorporated into the multidosage formulation of EZM." @default.
- W3036358487 created "2020-06-25" @default.
- W3036358487 creator A5015561526 @default.
- W3036358487 creator A5017833096 @default.
- W3036358487 creator A5022966942 @default.
- W3036358487 creator A5038994371 @default.
- W3036358487 creator A5044674711 @default.
- W3036358487 creator A5062602564 @default.
- W3036358487 creator A5064688851 @default.
- W3036358487 creator A5065090912 @default.
- W3036358487 creator A5076360802 @default.
- W3036358487 creator A5085249589 @default.
- W3036358487 date "2020-06-19" @default.
- W3036358487 modified "2023-10-12" @default.
- W3036358487 title "Formation of Antihyperlipidemic Nano-Ezetimibe from Volatile Microemulsion Template for Enhanced Dissolution Profile" @default.
- W3036358487 cites W1916833867 @default.
- W3036358487 cites W1970535740 @default.
- W3036358487 cites W1972314573 @default.
- W3036358487 cites W1986937151 @default.
- W3036358487 cites W1991035124 @default.
- W3036358487 cites W1992273861 @default.
- W3036358487 cites W1994546421 @default.
- W3036358487 cites W2005896555 @default.
- W3036358487 cites W2015278293 @default.
- W3036358487 cites W2034129765 @default.
- W3036358487 cites W2035490983 @default.
- W3036358487 cites W2038408723 @default.
- W3036358487 cites W2044274927 @default.
- W3036358487 cites W2059127448 @default.
- W3036358487 cites W2070396908 @default.
- W3036358487 cites W2079097966 @default.
- W3036358487 cites W2081160397 @default.
- W3036358487 cites W2083274240 @default.
- W3036358487 cites W2087643277 @default.
- W3036358487 cites W2088204759 @default.
- W3036358487 cites W2093224105 @default.
- W3036358487 cites W2109081474 @default.
- W3036358487 cites W2119186714 @default.
- W3036358487 cites W2132081026 @default.
- W3036358487 cites W2151823004 @default.
- W3036358487 cites W2229813984 @default.
- W3036358487 cites W2278505131 @default.
- W3036358487 cites W2295348757 @default.
- W3036358487 cites W2298809179 @default.
- W3036358487 cites W2313400375 @default.
- W3036358487 cites W2316549839 @default.
- W3036358487 cites W2319658045 @default.
- W3036358487 cites W2324370391 @default.
- W3036358487 cites W2344300587 @default.
- W3036358487 cites W2411242552 @default.
- W3036358487 cites W2514050794 @default.
- W3036358487 cites W2518509288 @default.
- W3036358487 cites W2564689313 @default.
- W3036358487 cites W2568965654 @default.
- W3036358487 cites W2586192983 @default.
- W3036358487 cites W2589127358 @default.
- W3036358487 cites W2592374624 @default.
- W3036358487 cites W2604986354 @default.
- W3036358487 cites W2607648677 @default.
- W3036358487 cites W2782375059 @default.
- W3036358487 cites W2784143496 @default.
- W3036358487 cites W2886132527 @default.
- W3036358487 cites W2886907409 @default.
- W3036358487 cites W2890167612 @default.
- W3036358487 cites W2895891965 @default.
- W3036358487 cites W2899968371 @default.
- W3036358487 cites W2944340054 @default.
- W3036358487 cites W2960481742 @default.
- W3036358487 cites W2973595439 @default.
- W3036358487 cites W2984206614 @default.
- W3036358487 doi "https://doi.org/10.1021/acs.langmuir.0c01016" @default.
- W3036358487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32551692" @default.
- W3036358487 hasPublicationYear "2020" @default.
- W3036358487 type Work @default.
- W3036358487 sameAs 3036358487 @default.
- W3036358487 citedByCount "11" @default.
- W3036358487 countsByYear W30363584872021 @default.
- W3036358487 countsByYear W30363584872022 @default.
- W3036358487 countsByYear W30363584872023 @default.
- W3036358487 crossrefType "journal-article" @default.
- W3036358487 hasAuthorship W3036358487A5015561526 @default.
- W3036358487 hasAuthorship W3036358487A5017833096 @default.
- W3036358487 hasAuthorship W3036358487A5022966942 @default.
- W3036358487 hasAuthorship W3036358487A5038994371 @default.
- W3036358487 hasAuthorship W3036358487A5044674711 @default.
- W3036358487 hasAuthorship W3036358487A5062602564 @default.
- W3036358487 hasAuthorship W3036358487A5064688851 @default.
- W3036358487 hasAuthorship W3036358487A5065090912 @default.
- W3036358487 hasAuthorship W3036358487A5076360802 @default.
- W3036358487 hasAuthorship W3036358487A5085249589 @default.
- W3036358487 hasConcept C127413603 @default.
- W3036358487 hasConcept C13965031 @default.
- W3036358487 hasConcept C14631669 @default.
- W3036358487 hasConcept C155672457 @default.
- W3036358487 hasConcept C171250308 @default.
- W3036358487 hasConcept C178790620 @default.
- W3036358487 hasConcept C185592680 @default.
- W3036358487 hasConcept C190119865 @default.